ASCO: Pfizer scores in lung, colorectal and prostate cancer but key readouts still to come
BioSpace
Pfizer showcased multiple late-breakers at the American Society of Clinical Oncology's annual conference but its biggest data are expected later this year.
pharminent
June 2, 2026 (Last updated: June 3, 2026)
BioSpace
Pfizer showcased multiple late-breakers at the American Society of Clinical Oncology’s annual conference but its biggest data are expected later this year.
